SEC Form 4 · accession 0001179110-16-025082
Neos Therapeutics, Inc. · NEOS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas P McDonnell
Officer — Chief Commercial Officer
Period of report
May 19, 2016
Accepted (ET)
May 19, 2016 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 19, 2016 | P | 3,000 | $7.557 | A | 3,000 | D |
Table II — derivative securities
No Table II lines on this filing.